Published: August 14, 2013 at 9:49 am

Oracle’s Ellison says Google’s Page acted ‘evil’ (CRN)Google Inc (NASDAQ:GOOG)‘s informal motto is “don’t be evil,” but outspoken Silicon Valley billionaire Larry Ellison has accused the Internet company’s CEO, Larry Page, of acting “absolutely evil.” Ellison, the CEO and co-founder of software giant Oracle Corporation (NASDAQ:ORCL), has long been famous for his zingers against business foes. He targeted Page as the two companies square off in a U.S. appeals court over a bitter lawsuit involving Google Inc (NASDAQ:GOOG)’s Android operating system. “We just think they took our stuff, and that was wrong,” Ellison said in an interview with Charlie Rose on “CBS This Morning,” which was aired on Tuesday.

Google Enterprise blog featured South Bend business and the Goshen business that helped them (eTruth)
As part of National Small Business Week in mid-June, the Google Inc (NASDAQ:GOOG) Enterprise Blog featured a post by the head of a South Bend company. In that post, Jeremy Davidson, CEO of Monroe Restoration, talked about how Goshen’s TechKnowledgey, Inc., helped them get onto a Google Inc (NASDAQ:GOOG)-based platform after a server crash. Google Inc (NASDAQ:GOOG) sent a video crew to northern Indiana to interview Davidson and TechKnowledgey founder Boyd Smith. The short video features some nice views of some easy-to-recognize Goshen locations and features Davidson and Smith talking together about their experience working with each other.

Google CEO Sells $18,369,081.09 in Stock (GOOG) (MideastTime)
Google Inc (NASDAQ:GOOG) CEO Lawrence Page unloaded 20,833 shares of the company’s stock on the open market in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $881.73, for a total transaction of $18,369,081.09. Following the sale, the chief executive officer now directly owns 85,000 shares in the company. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. A number of analysts have recently weighed in on Google Inc (NASDAQ:GOOG) shares. Analysts at TheStreet reiterated a “buy” rating on shares of Google Inc (NASDAQ:GOOG) in a research note to investors on Tuesday, August 6th.

Google Play Store ‘Package File Invalid’ Error Being Investigated By Google (Geeky-Gadgets)
Google Inc (NASDAQ:GOOG) has acknowledge that there is an issue that is causing visitors to the Google Play Store to receive an ‘Package File Invalid’ error and is now investigating the cause, although a fix has not been found as yet. Google Inc (NASDAQ:GOOG) released their new Google Play Store app a few days ago and while it has been successfully installed on a majority of devices, reported from Android users about the Google Play Store ‘Package File Invalid’ error have prompted Google Inc (NASDAQ:GOOG) to take action. …Currently there are no work arounds for the error, so if you experiencing problems you will need to wait until Google Inc (NASDAQ:GOOG) can release a fix. You can keep up to date on developments here.

Apple’s app store makes twice the money that Google’s Play store does (CNMEOnline)Apple Inc. (NASDAQ:AAPL)’s App Store still pulls in twice as much revenue as the Google Inc (NASDAQ:GOOG) Play Store, despite the continued growth in Android smartphone use, according to a report from mobile app tracking firm Distimo. However, Android app sales have pulled closer to iOS numbers over the past six months, the report said – app revenues on the Play Store rose by 67 percent over that period, compared to 15 percent for the App Store. Android users in Japan and South Korea accounted for much of the gains seen on that platform, Distimo said, despite the fact that the U.S. still drives more mobile app spending than any other single country. Revenues for Google Inc (NASDAQ:GOOG) Play in South Korea far outstripped Apple Inc. (NASDAQ:AAPL)’s — not surprising, given Android powerhouse Samsung’s home-field dominance.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.